FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203726360> ?p ?o ?g. }

• W3203726360 abstract "To investigate the effect of the combination of Wharton's jelly derived mesenchymal stem cells (WJ-MSC) and high frequency repetitive electromagnetic stimulation (rEMS) in the therapy of toxic optic neuropathies with severe symptoms after the available current therapy modalities which were unsucessful.This prospective, open-label clinical phase-3 study was conducted at Ankara University Faculty of Medicine, Department of Ophthalmology between April 2019 and April 2021. Thirty-six eyes of 18 patients with toxic optic neuropathy (TON) were included in the study. Within 1-3 months after the emergency interventions, patients with various degrees of sequela visual disturbances were studied in this clinical trial. The cases were divided into three groups according to similar demographic characteristics. Group 1: Consists of 12 eyes of 12 patients treated with the WJ-MSC and rEMS combination in one eye. Group 2: Consists of 12 eyes of 12 patients treated with only rEMS in one eye. Group 3: Consists of 12 eyes of six patients treated with only WJ-MSC in both eyes. The course was evaluated by comparing the quantitive functional and structural assessment parameters measured before and at the fourth month of applications in each group.The mean best corrected visual acuity (BCVA) delta change percentages of the groups can be ranked as: Group 1 (47%) > Group 3 (32%) > Group 2 (21%). The mean fundus perimetry deviation index (FPDI) delta change percentages of the groups can be ranked as: Group 1 (95%) > Group 2 (33%) > Group 3 (27%). The mean ganglion cell complex (GCC) thickness delta change (decrease in thickness) percentages can be ranked as: Group 1 (- 21%) > Group 3 (- 15%) > Group 2 (- 13%). The visual evoked potential (VEP) P100 latency delta change percentages of the groups can be ranked as: Group 1 (- 18%) > Group 3 (- 10%) > Group 2 (- 8%). The P100 amplitude delta change percentages of the groups can be ranked as: Group 1 (105%) > Group 3 (83%) > Group 2 (24%).Toxic optic neuropathies are emergent pathologies that can result in acute and permanent blindness. After poisoning with toxic substances, progressive apoptosis continues in optic nerve axons and ganglion cells. After the proper first systemic intervention in intensive care clinic, the WJ-MSC and rEMS combination seems very effective in the short-term period in cases with TON. To prevent permanent blindness, a combination of WJ-MSC and rEMS application as soon as possible may increase the chance of success in currently untreatable cases. Trial Registration ClinicalTrials.gov ID: NCT04877067." @default.
• W3203726360 created "2021-10-11" @default.
• W3203726360 creator A5015763940 @default.
• W3203726360 creator A5024014905 @default.
• W3203726360 date "2021-09-27" @default.
• W3203726360 modified "2023-10-16" @default.
• W3203726360 title "Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation" @default.
• W3203726360 cites W1503587500 @default.
• W3203726360 cites W1827619602 @default.
• W3203726360 cites W1967270924 @default.
• W3203726360 cites W1973772529 @default.
• W3203726360 cites W1980482098 @default.
• W3203726360 cites W2040808975 @default.
• W3203726360 cites W2046851657 @default.
• W3203726360 cites W2048413661 @default.
• W3203726360 cites W2090635662 @default.
• W3203726360 cites W2119857404 @default.
• W3203726360 cites W2127457454 @default.
• W3203726360 cites W2301068131 @default.
• W3203726360 cites W23225706 @default.
• W3203726360 cites W2338999534 @default.
• W3203726360 cites W2552199680 @default.
• W3203726360 cites W2580767461 @default.
• W3203726360 cites W2708242294 @default.
• W3203726360 cites W2768132803 @default.
• W3203726360 cites W2769465109 @default.
• W3203726360 cites W2774977719 @default.
• W3203726360 cites W2789632549 @default.
• W3203726360 cites W2791062035 @default.
• W3203726360 cites W2794850688 @default.
• W3203726360 cites W2894366344 @default.
• W3203726360 cites W2898736556 @default.
• W3203726360 cites W2899777911 @default.
• W3203726360 cites W2936188734 @default.
• W3203726360 cites W2945069273 @default.
• W3203726360 cites W2957165718 @default.
• W3203726360 cites W2958515608 @default.
• W3203726360 cites W2966100568 @default.
• W3203726360 cites W2973775330 @default.
• W3203726360 cites W2978131022 @default.
• W3203726360 cites W3006696679 @default.
• W3203726360 cites W3011740445 @default.
• W3203726360 cites W3012601512 @default.
• W3203726360 cites W3016867131 @default.
• W3203726360 cites W3022448788 @default.
• W3203726360 cites W3048747432 @default.
• W3203726360 cites W3093892302 @default.
• W3203726360 cites W3117185967 @default.
• W3203726360 cites W4378677896 @default.
• W3203726360 cites W312694010 @default.
• W3203726360 doi "https://doi.org/10.1186/s13287-021-02577-2" @default.
• W3203726360 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8477499" @default.
• W3203726360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34579767" @default.
• W3203726360 hasPublicationYear "2021" @default.
• W3203726360 type Work @default.
• W3203726360 sameAs 3203726360 @default.
• W3203726360 citedByCount "2" @default.
• W3203726360 countsByYear W32037263602023 @default.
• W3203726360 crossrefType "journal-article" @default.
• W3203726360 hasAuthorship W3203726360A5015763940 @default.
• W3203726360 hasAuthorship W3203726360A5024014905 @default.
• W3203726360 hasBestOaLocation W32037263601 @default.
• W3203726360 hasConcept C118487528 @default.
• W3203726360 hasConcept C119577978 @default.
• W3203726360 hasConcept C141071460 @default.
• W3203726360 hasConcept C142724271 @default.
• W3203726360 hasConcept C198826908 @default.
• W3203726360 hasConcept C2777609351 @default.
• W3203726360 hasConcept C2778233873 @default.
• W3203726360 hasConcept C2778257484 @default.
• W3203726360 hasConcept C2780827179 @default.
• W3203726360 hasConcept C2780837183 @default.
• W3203726360 hasConcept C71924100 @default.
• W3203726360 hasConcept C7243750 @default.
• W3203726360 hasConceptScore W3203726360C118487528 @default.
• W3203726360 hasConceptScore W3203726360C119577978 @default.
• W3203726360 hasConceptScore W3203726360C141071460 @default.
• W3203726360 hasConceptScore W3203726360C142724271 @default.
• W3203726360 hasConceptScore W3203726360C198826908 @default.
• W3203726360 hasConceptScore W3203726360C2777609351 @default.
• W3203726360 hasConceptScore W3203726360C2778233873 @default.
• W3203726360 hasConceptScore W3203726360C2778257484 @default.
• W3203726360 hasConceptScore W3203726360C2780827179 @default.
• W3203726360 hasConceptScore W3203726360C2780837183 @default.
• W3203726360 hasConceptScore W3203726360C71924100 @default.
• W3203726360 hasConceptScore W3203726360C7243750 @default.
• W3203726360 hasFunder F4320322240 @default.
• W3203726360 hasIssue "1" @default.
• W3203726360 hasLocation W32037263601 @default.
• W3203726360 hasLocation W32037263602 @default.
• W3203726360 hasLocation W32037263603 @default.
• W3203726360 hasLocation W32037263604 @default.
• W3203726360 hasOpenAccess W3203726360 @default.
• W3203726360 hasPrimaryLocation W32037263601 @default.
• W3203726360 hasRelatedWork W1964646944 @default.
• W3203726360 hasRelatedWork W1992784126 @default.
• W3203726360 hasRelatedWork W2126300298 @default.
• W3203726360 hasRelatedWork W2339496405 @default.
• W3203726360 hasRelatedWork W2393550787 @default.
• W3203726360 hasRelatedWork W2401921420 @default.

• next